Herpes simplex virus and varicella-zoster virus: Why do these human alphaherpesviruses behave so differently from one another?

Reviews in Medical Virology

Volumn 15, Issue 6, 2005, Pages 393-406

  Mori, Isamu ^a   Nishiyama, Yukihiro ^b  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AIRBORNE INFECTION; AUTONOMIC GANGLION; CELL FREE SYSTEM; DNA SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HERPES SIMPLEX VIRUS; HERPES VIRUS; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; MOLECULAR EVOLUTION; NONHUMAN; REVIEW; SEQUENCE ANALYSIS; SKIN INJURY; VARICELLA ZOSTER VIRUS; VIRAL GENETICS; VIRION; VIROGENESIS; VIRUS CLASSIFICATION; VIRUS DNA CELL DNA INTERACTION; VIRUS ENVELOPE; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANIMALS; GENOME, VIRAL; HERPES SIMPLEX; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; SIMPLEXVIRUS; SPECIES SPECIFICITY; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 27744524532     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.478     Document Type: Review

References (117)

1. Roizman B, Carmichael LE, Deinhardt F, et al. Herpesviridae. Definition, provisional nomenclature, and taxonomy. Intervirology 1981; 16: 201-217.
2. Minson AC, Davison A, Eberle R, et al. Herpesviridae. In Virus Taxonomy, van Regenmortel MHV, Fauquet CM, Bishop DHL, et al. (eds). Academic Press: New York, 2000; 203-225.
3. McGeoch DJ. The genomes of the human herpesviruses: contents, relationship, and evolution. Ann Rev Microbiol 1989; 43: 235-265.
4. McGeoch DJ, Cook S, Dolan A, et al. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol 1995; 247: 443-458.
5. McGeoch DJ, Davison AJ. The molecular evolutionary history of the herpesviruses. In Origin and Evolution of Viruses, Domingo E, Webster R, Holland J (eds). Academic Press: London, 1999; 441-465.
6. McGeoch DJ, Dolan A, Ralph AC. Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol 2000; 74: 10401-10406.
7. Grose C. Varicella-zoster virus: less immutable than once thought. Pediatrics 1999; 103: 1027-1028.
8. Cohen JI. Genomic structure and organization of varicella-zoster virus. Contrib Microbiol 1999; 3: 10-20.
9. Nishiyama Y. Herpes simplex virus gene products: the accessories reflect her lifestyle well. Rev Med Virol 2004; 14: 33-46.
10. Rawson H, Crampin A, Noah N. Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. Br Med J 2001; 323: 1091-1093.
11. Grant RM, Weitzman SS, Sherman CG, et al. Fulminant disseminated varicella zoster virus infection without skin involvement. J Clin Virol 2002; 24: 7-12.
12. Youssef R, Shaker O, Sobeih S, et al. Detection of herpes simplex virus DNA in serum and oral secretions during acute recurrent herpes labialis. J Dermatol 2002; 29: 404-410.
13. Harel L, Smetana Z, Prais D, et al. Presence of viremia in patients with primary herpetic gingivostomatitis. Clin Infect Dis 2004; 39: 636-640.
14. Asano Y, Itakura N, Kajita Y, et al. Severity of viremia and clinical findings in children with varicella. J Infect Dis 1990; 161: 1095-1098.
15. Ito Y, Kimura H, Hara S, et al. Investigation of varicella-zoster virus DNA in lymphocyte subpopulations by quantitative PCR assay. Microbiol Immunol 2001; 45: 267-269.
16. Sacks SL, Griffiths PD, Corey L, et al. HSV shedding. Antiviral Res 2004; 63S1: S19-S26.
17. Huff JL, Barry PA. B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease. Emerg Infect Dis 2003; 9: 246-250.
18. Gray WL. Pathogenesis of simian varicella virus. J Med Virol 2003; 70: S4-S8.
19. Gray WL. Simian varicella: a model for human varicella-zoster virus infections. Rev Med Virol 2004; 14: 363-381.
20. Campadelli-Fiume G, Cocchi F, Menotti L, et al. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol 2000; 10: 305-319.
21. Richart SM, Simpson SA, Krummenacher C, et al. Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by nectin-1/HveC. J Virol 2003; 77: 3307-3311.
22. Singh IP, Chopra AK, Coppenhaver DH, et al. Lipoproteins account for part of the broad non-specific antiviral activity of human serum. Antiviral Res 1999; 42: 211-218.
23. Singh IP, Baron S. Innate defences against viraemia. Rev Med Virol 2000; 10: 395-403.
24. Singh IP, Coppenhaver DH, Chopra AK, et al. Innate gastrointestinal immunity: characterization of broadly active viral inhibitors. Antiviral Res 2001; 49: 157-167.
25. Thormar H, Isaacs CE, Brown HR, et al. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 1987; 31: 27-31.
26. Thormar H, Bergsson G, Gunnarsson E, et al. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sex Transm Infect 1999; 75: 181-185.
27. Hilmarsson H, Kristmundsdottir T, Thormar H. Virucidal activities of medium- and long-chain fatty alcohols, fatty acids and monoglycerides against herpes simplex virus types 1 and 2: comparison at different pH levels. APMIS 2005; 113: 58-65.
28. Zhu Z, Gershon MD, Ambron R, et al. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci USA 1995; 92: 3546-3550.
29. Connolly SA, Whitbeck JC, Rux AH, et al. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC (nectin-1) with different affinities. Virology 2001; 280: 7-18.
30. Schmidt J, Gerdts V, Beyer J, et al. Glycoprotein D-independent infectivity of pseudorabies virus results in an alteration of in vivo host range and correlates with mutations in glycoproteins B and H. J Virol 2001; 75: 10054-10064.
31. Cole NL, Grose C. Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus. Rev Med Virol 2003; 13: 207-222.
32. Mainka C, Fuß B, Geiger H, et al. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 1998; 56: 91-98.
33. White TM, Gilden DH. Varicella virus-mononuclear cell interaction. Adv Virus Res 2003; 62: 1-17.
34. Abendroth A, Morrow G, Cunningham AL, et al. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J Virol 2001; 75: 6183-6192.
35. Soong W, Schultz JC, Patera AC, et al. Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol 2000; 74: 1864-1870.
36. + T lymphocytes that express activation, memory, and skin homing markers. J Virol 2002; 76: 11425-11433.
37. Koenig A, Wolff MH. Infectivity of separated peripheral blood mononuclear cell subpopulations by varicella-zoster virus (VZV). J Med Virol 2003; 70: S59-S63.
38. + T lymphocytes and epidermal cells in SCID-hu mice. J Virol 1995; 69: 5236-5242.
39. Moffat J, Ito H, Sommer M, et al. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J Virol 2002; 76: 8468-8471.
40. Fuchs M, Hubert P, Detterer J, et al. Detection of bovine herpesvirus type 1 in blood from naturally infected cattle by using a sensitive PCR that discriminates between wild-type virus and virus lacking glycoprotein E. J Clin Microbiol 1999; 37: 2498-2507.
41. Nauwynck HJ, Pensaert MB. Cell-free and cell-associated viremia in pigs after oronasal infection with Aujeszky's disease virus. Vet Microbiol 1995; 43: 307-314.
42. Chen JJ, Zhu Z, Gershon AA, et al. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 2004; 119: 915-926.
43. Wallis C, Yang C-S, Melnick JL. Effect of cations on thermal inactivation of vaccinia, herpes simplex, and adenoviruses. J Immunol 1962; 89: 41-46.
44. Myers MG, Ekwo EE, Pitts AK. The stability of herpes simplex virus on vaginal tampons. J Med Virol 1979; 3: 203-206.
45. Levin MJ, Leventhal S, Masters HA. Factors influencing quantitative isolation of varicella-zoster virus. J Clin Microbiol 1984; 19: 880-883.
46. Fanget B, Françon A. A varicella vaccine stable at 5°C. Dev Biol Stand 1996; 87: 167-171.
47. Mori I, Nishiyama Y, Yokochi T, et al. Olfactory transmission of neurotropic viruses. J Neurovirol 2005; 11: 129-137.
48. Theil D, Horn AKE, Derfuss T, et al. Prevalence and distribution of HSV-1, VZV, and HHV-6 in human cranial nerve nuclei III, IV, VI, VII, and XII. J Med Virol 2004; 74: 102-106.
49. Kennedy PGE, Grinfeld E, Gow JW. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci USA 1998; 95: 4658-4662.
50. Kent JR, Kang W, Miller CG, et al. Herpes simplex virus latency-associated transcript gene function. J Neurovirol 2003; 9: 285-290.
51. Perng G-C, Jones C, Ciacci-Zanella J, et al. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000; 287: 1500-1503.
52. Henderson G, Peng W, Jin L, et al. Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript. J Neurovirol 2002; 8(Suppl 2): 103-111.
53. Jones C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev 2003; 16: 79-95.
54. Thomas SK, Lilley CE, Latchman DS, et al. A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J Virol 2002; 76: 4056-4067.
55. Liu T, Khanna KM, Carriere BN, et al. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 2001; 75: 11178-11184.
56. + T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 2003; 18: 593-603.
57. Feldman LT, Ellison AR, Voytek CC, et al. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci USA 2002; 99: 978-983.
58. Theil D, Derfuss T, Paripovic I, et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 2003; 163: 2179-2184.
59. Hood C, Cunningham AL, Slobedman B, et al. Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblast are susceptible: evidence for a cell-type-specific apoptotic response. J Virol 2003; 77: 12852-12864.
60. Baiker A, Fabel K, Cozzio A, et al. Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci USA 2004; 101: 10792-10797.
61. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, et al. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-645.
62. Mitchell BM, Bloom DC, Cohrs RJ, et al. Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol 2003; 9: 194-204.
63. Cohrs RJ, Gilden DH, Mahalingam R. Varicella zoster virus latency, neurological disease and experimental models: an update. Front Biosci 2004; 9: 751-762.
64. Grinfeld E, Kennedy PGE. Translation of varicella-zoster virus genes during human ganglionic latency. Virus Genes 2004; 29: 317-319.
65. Cohrs RJ, Gilden DH, Kinchington PR, et al. Varicella-zoster virus gene 66 transcription and translation in latently infected human ganglia. J Virol 2003; 77: 6660-6665.
66. Kinchington PR. Latency of varicella zoster virus: a persistently perplexing state. Front Biosci 1999; 4: d200-d211.
67. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-zoster virus infections of the nervous system. Arch Pathol Lab Med 2001; 125: 770-780.
68. Gilden DH, Cohrs RJ, Mahalingam R. VZV vasculopathy and postherpetic neuralgia. Progress and perspective on antiviral therapy. Neurology 2005; 64: 21-25.
69. Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-α/β revisited. Nat Rev Mol Cell Biol 2001; 2: 378-386.
70. Leib DA. Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr Top Microbiol Immunol 2002; 269: 171-185.
71. Duerst RJ, Morrison LA. Innate immunity to herpes simplex virus type 2. Viral Immunol 2003; 16: 475-490.
72. Chee AV, Lopez P, Pandolfi PP, et al. Promyelocytic leukemia protein mediates interferon-based antiherpes simplex virus 1 effects. J Virol 2003; 77: 7101-7105.
73. Eidson KM, Hobbs WE, Manning BJ, et al. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol 2002; 76: 2180-2191.
74. Lin R, Noyce RS, Collins SE, et al. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 2004; 78: 1675-1684.
75. Bauer D, Tampé R. Herpes viral proteins blocking the transporter associated with antigen processing TAP. From genes to function and structure. Curr Top Microbiol Immunol 2002; 269: 87-99.
76. Sloan DD, Zahariadis G, Posavad CM, et al. CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J Immunol 2003; 171: 6733-6741.
77. Desloges N, Rahaus M, Wolff MH. Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. J Gen Virol 2005; 86: 1-6.
78. Desloges N, Rahaus M, Wolff MH. Varicella-zoster virus does not significantly induce the cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle. Med Microbiol Immunol 2005; 194: 25-31.
79. Abendroth A, Lin I, Slobedman B, et al. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001; 75: 4878-4888.
80. Nikkels AF, Sadzot-Delvaux C, Piérard GE. Absence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during herpes zoster. Another immune evasion strategy? Am J Dermatopathol 2004; 26: 27-32.
81. Abendroth A, Slobedman B, Lee E, et al. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J Virol 2000; 74: 1900-1907.
82. Ku C-C, Zerboni L, Ito H, et al. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-α. J Exp Med 2004; 200: 917-925.
83. Perelygina L, Zhu L, Zurkuhlen H, et al. Complete sequence and comparative analysis of the genome of herpes B virus (Cercopithecine herpesvirus 1) from a rhesus monkey. J Virol 2003; 77: 6167-6177.
84. Tyler SD, Peters GA, Severini A. Complete genome sequence of cercopithecine herpesvirus 2 (SA8) and comparison with other simplexviruses. Virology 2005; 331: 429-440.
85. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986; 67: 1759-1816.
86. Gray WL, Starnes B, White MW, et al. The DNA sequence of the simian varicella virus genome. Virology 2001; 284: 123-130.
87. Crabb BS, Studdert MJ. Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv Virus Res 1995; 45: 153-190.
88. Telford EAR, Watson MS, McBride K, et al. The DNA sequence of equine herpesvirus-1. Virology 1992; 189: 304-316.
89. Telford EAR, Watson MS, Perry J, et al. The DNA sequence of equine herpesvirus-4. J Gen Virol 1998; 79: 1197-1203.
90. Tikoo SK, Campos M, Babiuk LA. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv Virus Res 1995; 45: 191-223.
91. Delhon G, Moraes MP, Lu Z, et al. Genome of bovine herpesvirus 5. J Virol 2003; 77: 10339-10347.
92. Klupp BG, Hengartner CJ, Mettenleiter TC, et al. Complete, annotated sequence of the pseudorabies virus genome. J Virol 2004; 78: 424-440.
93. 1 34.5, a gene nonessential for growth in culture. Science 1990; 250: 1262-1266.
94. Cockrell AS, Muggeridge MI. Herpes simplex virus 2 UL45 is a type II membrane protein. J Virol 1998; 72: 4430-4433.
95. Haanes EJ, Nelson CM, Soule CL, et al. The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion. J Virol 1994; 68: 5825-5834.
96. Koshizuka T, Goshima F, Takakuwa H, et al. Identification and characterization of the UL56 gene product of herpes simplex virus type 2. J Virol 2002; 76: 6718-6728.
97. Berkowitz C, Moyal M, Rösen-Wolff A, et al. Herpes simplex virus type 1 (HSV-1) UL56 gene is involved in viral intraperitoneal pathogenicity to immunocompetent mice. Arch Virol 1994; 134: 73-83.
98. Koshizuka T, Kawaguchi Y, Nishiyama Y. Herpes simplex virus type 2 membrane proteins UL56 associates with the kinesin motor protein KIF1A. J Gen Virol 2005; 86: 527-533.
99. Jiang Y-M, Yamada H, Goshima F, et al. Characterization of the herpes simplex virus type 2 (HSV-2) US2 gene product and a US2-deficient HSV-2 mutant. J Gen Virol 1998; 79: 2777-2784.
100. Goshima F, Watanabe D, Suzuki H, et al. The US2 gene product of herpes simplex virus type 2 interacts with cytokeratin 18. Arch Virol 2001; 146: 2201-2209.
101. Frame MC, Marsden HS, McGeoch DJ. Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. J Gen Virol 1986; 67: 745-751.
102. Tran LC, Kissner JM, Westerman LE, et al. A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proc Natl Acad Sci USA 2000; 97: 1818-1822.
103. Ghiasi H, Nesburn AB, Cai S, et al. The US5 open reading frame of herpes simplex virus type 1 does encode a glycoprotein (gJ). Intervirology 1998; 41: 91-97.
104. Jerome KR, Chen Z, Lang R, et al. HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas. J Immunol 2001; 167: 3928-3935.
105. Zhou G, Avitabile E, Campadelli-Fiume G, et al. The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1. J Virol 2003; 77: 3759-3767.
106. Roller RJ, Monk LL, Stuart D, et al. Structure and function in the herpes simplex virus 1 RNA-binding protein Us11: mapping of the domain required for ribosomal and nucleolar association and RNA binding in vitro. J Virol 1996; 70: 2842-2851.
107. Diefenbach RJ, Miranda-Saksena M, Diefenbach E, et al. Herpes simplex virus tegument protein US11 interacts with conventional kinesin heavy chain. J Virol 2002; 76: 3282-3291.
108. Duc Dodon M, Mikaélian I, Sergeant A, et al. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production. Virology 2000; 270: 43-53.
109. Koshizuka T, Takakuwa H, Goshima F, et al. The US11 gene product of herpes simplex virus has intercellular trafficking activity. Biochem Biophys Res Commun 2001; 288: 597-602.
110. Mori I, Koshizuka T, Goshima F, et al. Intercellular trafficking activity of herpes simplex virus US11 gene product in the mouse brain. Brain Res Mol Brain Res 2005; 136: 158-163.
111. Cohen JI, Seidel KE. Varicell-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro. Virology 1995; 206: 835-842.
112. Sato H, Pesnicak L, Cohen JI. Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J Virol 2002; 76: 3575-3578.
113. Cohen JI, Seidel KE. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci USA 1993; 90: 7376-7380.
114. Reddy SM, Cox E, Iofin I, et al. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J Virol 1998; 72: 8083-8088.
115. Cox E, Reddy S, Iofin I, et al. Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture. Virology 1998; 250: 205-209.
116. Lubinski JM, Jiang M, Hook L, et al. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J Virol 2002; 76: 9232-9241.
117. Smiley JR. Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase? J Virol 2004; 78: 1063-1068.